Ascendis Pharma A/S (ASND)
258.06
+7.89
(+3.15%)
USD |
NASDAQ |
Nov 04, 16:00
258.06
0.00 (0.00%)
After-Hours: 17:15
Ascendis Pharma Total Return Price : 258.06 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 250.17 |
| November 02, 2026 | 248.98 |
| October 30, 2026 | 251.27 |
| October 29, 2026 | 253.00 |
| October 28, 2026 | 249.55 |
| October 27, 2026 | 245.85 |
| October 26, 2026 | 245.15 |
| October 23, 2026 | 243.37 |
| October 22, 2026 | 242.99 |
| October 21, 2026 | 238.90 |
| October 20, 2026 | 234.33 |
| October 19, 2026 | 229.95 |
| October 16, 2026 | 225.25 |
| October 15, 2026 | 226.62 |
| October 14, 2026 | 227.00 |
| October 13, 2026 | 223.21 |
| October 12, 2026 | 227.00 |
| October 09, 2026 | 229.23 |
| October 08, 2026 | 222.69 |
| October 07, 2026 | 228.41 |
| October 06, 2026 | 226.05 |
| October 05, 2026 | 228.03 |
| October 02, 2026 | 227.87 |
| October 01, 2026 | 227.31 |
| September 30, 2026 | 227.83 |
| Date | Value |
|---|---|
| September 29, 2026 | 228.07 |
| September 28, 2026 | 230.05 |
| September 25, 2026 | 225.60 |
| September 24, 2026 | 230.70 |
| September 23, 2026 | 223.13 |
| September 22, 2026 | 237.57 |
| September 21, 2026 | 237.59 |
| September 18, 2026 | 236.72 |
| September 17, 2026 | 239.04 |
| September 16, 2026 | 247.69 |
| September 15, 2026 | 239.77 |
| September 14, 2026 | 264.92 |
| September 11, 2026 | 263.52 |
| September 10, 2026 | 261.23 |
| September 09, 2026 | 260.81 |
| September 08, 2026 | 270.09 |
| September 04, 2026 | 270.56 |
| September 03, 2026 | 271.12 |
| September 02, 2026 | 267.31 |
| September 01, 2026 | 260.25 |
| August 31, 2026 | 263.04 |
| August 28, 2026 | 247.91 |
| August 27, 2026 | 249.36 |
| August 26, 2026 | 250.25 |
| August 25, 2026 | 252.99 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| BioMarin Pharmaceutical, Inc. | 57.13 |
| Novo Nordisk A/S | 42.17 |
| Evaxion AS | 3.05 |
| Genmab A/S | 55.08 |
| Zealand Pharma A/S | 34.63 |